Literature DB >> 1854609

Comparative pathology of breast cancer in a randomised trial of screening.

T J Anderson1, J Lamb, P Donnan, F E Alexander, A Huggins, B B Muir, A E Kirkpatrick, U Chetty, W Hepburn, A Smith.   

Abstract

In the Edinburgh Randomised Breast Screening Project (EBSP) to December 1988 there were 500 cancers in the study population invited to screening and 340 cancers identified in the control population. The size and negative lymph node status characteristics of invasive cancers from the two populations were significantly different (P less than 0.05). The cancers detected by screening were predominantly 'early stage', with 16% noninvasive (PTIS) and 42% invasive stage I (pT1 node negative), whereas cancers were frequently 'late stage' (more than pT2) and inoperable in nonattenders (44%) and controls (36%). Grouped according to customary size ranges of invasive cancers, the proportion of cases lymph node positive differed in those screen detected compared with controls, but the benefit in favour of screen detection was not constant. In comparisons of cancers detected at prevalence and incidence screens, as a test of conformity with screening theory, no significant differences were apparent according to size and lymph node status, yet the characteristics of histological type of cancer discriminated significantly (P less than 0.05). When these same histological characteristics were used to compare survival, the capacity to separate invasive cancers into two groups having good and poor survival probabilities was evident, with a significant improvement for the screen detected poor survival group compared with controls (P less than 0.05).

Entities:  

Mesh:

Year:  1991        PMID: 1854609      PMCID: PMC1977297          DOI: 10.1038/bjc.1991.251

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy).

Authors:  D Palli; M R Del Turco; E Buiatti; S Carli; S Ciatto; L Toscani; G Maltoni
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

2.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.

Authors:  C L Carter; C Allen; D E Henson
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

3.  Evidence on screening for breast cancer from a randomized trial.

Authors:  S Shapiro
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

4.  Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening.

Authors:  L Tabar; S W Duffy; U B Krusemo
Journal:  Eur J Cancer Clin Oncol       Date:  1987-07

5.  Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.

Authors:  P P Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

6.  Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project.

Authors:  T J Anderson; J Lamb; F Alexander; W Lutz; U Chetty; A P Forrest; A Kirkpatrick; B Muir; M M Roberts; A Huggins
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

7.  Analysis of interval breast carcinomas in a randomized screening trial in Stockholm.

Authors:  J Frisell; G Eklund; L Hellström; A Somell
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

8.  Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program.

Authors:  T Hatschek; G Fagerberg; O Stål; S Sullivan; J Carstensen; O Gröntoft; B Nordenskjöld
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

9.  The occurrence of interval cancers in the Nijmegen screening programme.

Authors:  P H Peeters; A L Verbeek; J H Hendriks; R Holland; M Mravunac; G P Vooijs
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

10.  Breast cancer screening programmes: the development of a monitoring and evaluation system.

Authors:  N E Day; D R Williams; K T Khaw
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

View more
  12 in total

1.  Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.

Authors:  J D Otten; J A van Dijck; P G Peer; H Straatman; A L Verbeek; M Mravunac; J H Hendriks; R Holland
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

2.  Screening for breast cancer. Maximise compliance as well as radiological sensitivity.

Authors:  T J Anderson; F E Alexander; A E Kirkpatrick
Journal:  BMJ       Date:  1995-04-15

3.  A study of interval breast cancer within the NHS breast screening programme.

Authors:  W K Cowan; B Angus; J C Gray; L G Lunt; S R al-Tamimi
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

4.  A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial.

Authors:  S E Pinder; C Duggan; I O Ellis; J Cuzick; J F Forbes; H Bishop; I S Fentiman; W D George
Journal:  Br J Cancer       Date:  2010-06-01       Impact factor: 7.640

5.  Evaluating the breast screening programme: the need for surgical audit.

Authors:  F Kee; D Gorman; W Odling-Smee
Journal:  J R Soc Med       Date:  1993-02       Impact factor: 5.344

6.  Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.

Authors:  M Quinn; E Allen
Journal:  BMJ       Date:  1995-11-25

7.  A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds.

Authors:  P A Holland; J Walls; C R Boggis; F Knox; A D Baildam; N J Bundred
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

Review 8.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

9.  Pathological and biological features of mammographically detected invasive breast carcinomas.

Authors:  R Rajakariar; R A Walker
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

10.  The impact of the first 3 years of breast cancer screening on the overall presentation of breast cancer.

Authors:  C Moody; A Corder; M A Mullee; P Guyer; C Rubin; M Cross; G T Royle; I Taylor
Journal:  J R Soc Med       Date:  1994-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.